Loading...

David Straus

Title(s)GI Fellow, Surgery
SchoolVc-health Sciences-schools
Address9300 Campus Point Drive #7220
La Jolla CA 92037
Phone000-000-NULL
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Next Questions - Classical Hodgkin Lymphoma (cHL). Clin Lymphoma Myeloma Leuk. 2020 Sep; 20 Suppl 1:S103-S104. Straus DJ. PMID: 32862849.
      View in: PubMed   Mentions:    Fields:    
    2. Treatment of Newly Diagnosed Classical Hodgkin Lymphoma. Clin Lymphoma Myeloma Leuk. 2020 Sep; 20 Suppl 1:S87-S88. Straus DJ. PMID: 32862883.
      View in: PubMed   Mentions:    Fields:    
    3. Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population. Leuk Lymphoma. 2020 Aug 26; 1-11. Ghione P, Qi S, Imber BS, Seshan V, Moskowitz A, Galasso N, Lunning M, Straus D, Sauter C, Dahi P, Dogan A, Yahalom J, Horwitz S. PMID: 32844695.
      View in: PubMed   Mentions:    Fields:    
    4. Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy. Leuk Lymphoma. 2020 Aug 25; 1-8. Straus D, Collins G, Walewski J, Zinzani PL, Grigg A, Sureda A, Illes A, Kim TM, Alekseev S, Specht L, Buccheri V, Younes A, Connors J, Forero-Torres A, Fenton K, Gautam A, Purevjal I, Liu R, Gallamini A. PMID: 32842815.
      View in: PubMed   Mentions:    Fields:    
    5. Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in The Rituximab-Era. Blood. 2020 Jul 30. Bobillo S, Joffe E, Lavery JA, Sermer D, Ghione P, Noy A, Caron PC, Hamilton AM, Hamlin PA, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens C, Palomba ML, Batlevi C, Straus DJ, von Keudell G, Zelenetz AD, Yahalom J, Dogan A, Seshan VE, Younes A. PMID: 32730585.
      View in: PubMed   Mentions:    Fields:    
    6. Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma. Blood Adv. 2020 Jul 28; 4(14):3382-3390. Sermer D, Bobillo S, Dogan A, Zhang Y, Seshan V, Lavery JA, Batlevi C, Caron P, Hamilton A, Hamlin P, Horwitz S, Joffe E, Kumar A, Matasar M, Noy A, Owens C, Moskowitz A, Palomba ML, Straus D, von Keudell G, Rodriguez-Rivera I, Falchi L, Zelenetz A, Yahalom J, Younes A. PMID: 32722781.
      View in: PubMed   Mentions:    Fields:    
    7. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups. Blood Cancer J. 2020 Jul 17; 10(7):74. Batlevi CL, Sha F, Alperovich A, Ni A, Smith K, Ying Z, Soumerai JD, Caron PC, Falchi L, Hamilton A, Hamlin PA, Horwitz SM, Joffe E, Kumar A, Matasar MJ, Moskowitz AJ, Moskowitz CH, Noy A, Owens C, Palomba LM, Straus D, von Keudell G, Zelenetz AD, Seshan VE, Younes A. PMID: 32678074.
      View in: PubMed   Mentions:    Fields:    
    8. Utilization of clinical genetic counseling among childhood and young adult cancer survivors in a registry trial. J Community Genet. 2020 Jul 16. Anderson N, Delavar A, Friedman DN, Joseph V, Mubdi N, Oeffinger KC, Sklar CA, Offit K, Matasar M, Raghunathan N, Antal Z, Straus D, Walsh M, Latham A, Tonorezos ES. PMID: 32676930.
      View in: PubMed   Mentions:
    9. ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study. Am J Hematol. 2020 May 17. Mondello P, Musolino C, Dogliotti I, Bohn JP, Cavallo F, Ferrero S, Botto B, Cerchione C, Nappi D, De Lorenzo S, Martinelli G, Wolf D, Schmitt C, Loseto G, Cuzzocrea S, Willenbacher W, Mian M, Straus DJ. PMID: 32419224.
      View in: PubMed   Mentions:    Fields:    
    10. Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study. Blood. 2020 Mar 05; 135(10):735-742. Straus DJ, Dlugosz-Danecka M, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Ramchandren R, Zinzani PL, Hutchings M, Connors JM, Radford J, Munoz J, Kim WS, Advani R, Ansell SM, Younes A, Miao H, Liu R, Fenton K, Forero-Torres A, Gallamini A. PMID: 31945149.
      View in: PubMed   Mentions: 2     Fields:    
    11. Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma. Eur J Cancer. 2020 02; 126:78-90. Batlevi CL, Sha F, Alperovich A, Ni A, Smith K, Ying Z, Gerecitano JF, Hamlin PA, Horwitz SM, Joffe E, Kumar A, Matasar MJ, Moskowitz AJ, Moskowitz CH, Noy A, Owens C, Palomba LM, Straus D, von Keudell G, Zelenetz AD, Seshan VE, Luminari S, Marcheselli L, Federico M, Younes A. PMID: 31927165.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    12. Incidence of infectious complications with the combination of bendamustine and an anti-CD20 monoclonal antibody. Leuk Lymphoma. 2020 02; 61(2):364-369. Sarlo KM, Dixon BN, Ni A, Straus DJ. PMID: 31603363.
      View in: PubMed   Mentions:    Fields:    
    13. Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma. Blood. 2019 10 10; 134(15):1238-1246. Stephens DM, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, LaCasce AS, Barr PM, Knopp MV, Hsi ED, Leonard JP, Kahl BS, Smith SM, Friedberg JW. PMID: 31331918.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    14. Cardiovascular Complications Associated with Mediastinal Radiation. Curr Treat Options Cardiovasc Med. 2019 Jun 04; 21(7):31. Lee Chuy K, Nahhas O, Dominic P, Lopez C, Tonorezos E, Sidlow R, Straus D, Gupta D. PMID: 31161453.
      View in: PubMed   Mentions:
    15. Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse. Blood Cancer J. 2019 05 20; 9(6):50. Kumar A, Sha F, Toure A, Dogan A, Ni A, Batlevi CL, Palomba MLM, Portlock C, Straus DJ, Noy A, Horwitz SM, Moskowitz A, Hamlin P, Moskowitz CH, Matasar MJ, Zelenetz AD, Younes A. PMID: 31110172.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood. 2019 05 16; 133(20):2121-2129. Borchmann S, Joffe E, Moskowitz CH, Zelenetz AD, Noy A, Portlock CS, Gerecitano JF, Batlevi CL, Caron PC, Drullinsky P, Hamilton A, Hamlin PA, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens CN, Palomba ML, Younes A, Straus DJ. PMID: 30770396.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    17. Brentuximab Vedotin plus Chemotherapy in North American Subjects with Newly Diagnosed Stage III or IV Hodgkin Lymphoma. Clin Cancer Res. 2019 03 15; 25(6):1718-1726. Ramchandren R, Advani RH, Ansell SM, Bartlett NL, Chen R, Connors JM, Feldman T, Forero-Torres A, Friedberg JW, Gopal AK, Gordon LI, Kuruvilla J, Savage KJ, Younes A, Engley G, Manley TJ, Fenton K, Straus DJ. PMID: 30617130.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    18. Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure. Clinicoecon Outcomes Res. 2018; 10:629-641. Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, Straus DJ. PMID: 30410373.
      View in: PubMed   Mentions:
    19. Giant symptomatic gastric lipoma: A case report and literature review. Int J Surg Case Rep. 2018; 51:313-317. Amundson JR, Straus D, Azab B, Liu S, Garcia Buitrago MT, Yakoub D. PMID: 30245352.
      View in: PubMed   Mentions:
    20. Limited-Stage Hodgkin Lymphoma: Minimizing Toxicity. Cancer J. 2018 Sep/Oct; 24(5):223-229. Straus DJ. PMID: 30247257.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Cranial Chordoma: A New Preoperative Grading System. Neurosurgery. 2018 09 01; 83(3):403-415. Brito da Silva H, Straus D, Barber JK, Rostomily RC, Ferreira M, Sekhar LN. PMID: 29126120.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. Blood. 2018 09 06; 132(10):1013-1021. Straus DJ, Jung SH, Pitcher B, Kostakoglu L, Grecula JC, Hsi ED, Schöder H, Popplewell LL, Chang JE, Moskowitz CH, Wagner-Johnston N, Leonard JP, Friedberg JW, Kahl BS, Cheson BD, Bartlett NL. PMID: 30049811.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    23. Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay. Blood Cancer J. 2018 06 12; 8(6):60. Intlekofer AM, Joffe E, Batlevi CL, Hilden P, He J, Seshan VE, Zelenetz AD, Palomba ML, Moskowitz CH, Portlock C, Straus DJ, Noy A, Horwitz SM, Gerecitano JF, Moskowitz A, Hamlin P, Matasar MJ, Kumar A, van den Brink MR, Knapp KM, Pichardo JD, Nahas MK, Trabucco SE, Mughal T, Copeland AR, Papaemmanuil E, Moarii M, Levine RL, Dogan A, Miller VA, Younes A. PMID: 29895903.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    24. A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL. Blood. 2018 04 19; 131(16):1805-1808. Sauter CS, Matasar MJ, Schoder H, Devlin SM, Drullinsky P, Gerecitano J, Kumar A, Noy A, Palomba ML, Portlock CS, Straus DJ, Zelenetz AD, McCall SJ, Miller ST, Courtien AI, Younes A, Moskowitz CH. PMID: 29386196.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    25. Initial Hodgkin treatment of the frail elderly. Blood. 2017 12 28; 130(26):2813-2814. Straus DJ. PMID: 29284610.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma. N Engl J Med. 2018 01 25; 378(4):331-344. Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J. PMID: 29224502.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    27. Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma. Blood. 2017 11 16; 130(20):2196-2203. Moskowitz AJ, Schöder H, Gavane S, Thoren KL, Fleisher M, Yahalom J, McCall SJ, Cadzin BR, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz SM, Kumar A, Matasar M, Ni A, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Straus D, Younes A, Zelenetz AD, Moskowitz CH. PMID: 28874350.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    28. The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma. Clin Cancer Res. 2017 Aug 01; 23(15):4119-4126. Soumerai JD, Zelenetz AD, Moskowitz CH, Palomba ML, Hamlin PA, Noy A, Straus DJ, Moskowitz AJ, Younes A, Matasar MJ, Horwitz SM, Portlock CS, Konner JA, Gounder MM, Hyman DM, Voss MH, Fury MG, Gajria D, Carvajal RD, Ho AL, Beumer JH, Kiesel B, Zhang Z, Chen A, Little RF, Jarjies C, Dang TO, France F, Mishra N, Gerecitano JF. PMID: 28314788.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    29. Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma. Blood. 2016 09 15; 128(11):1458-64. Kumar A, Casulo C, Yahalom J, Schöder H, Barr PM, Caron P, Chiu A, Constine LS, Drullinsky P, Friedberg JW, Gerecitano JF, Hamilton A, Hamlin PA, Horwitz SM, Jacob AG, Matasar MJ, McArthur GN, McCall SJ, Moskowitz AJ, Noy A, Palomba ML, Portlock CS, Straus DJ, VanderEls N, Verwys SL, Yang J, Younes A, Zelenetz AD, Zhang Z, Moskowitz CH. PMID: 27458003.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    30. Learning curve for the transsphenoidal endoscopic endonasal approach to pituitary tumors. Br J Neurosurg. 2016 Dec; 30(6):637-642. Qureshi T, Chaus F, Fogg L, Dasgupta M, Straus D, Byrne RW. PMID: 27332969.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    31. US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816. J Clin Oncol. 2016 06 10; 34(17):2020-7. Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, Barr PM, Fanale MA, Knopp MV, Noy A, Hsi ED, Cook JR, Lechowicz MJ, Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher RI, Friedberg JW. PMID: 27069074.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    32. Radiation Therapy for Hodgkin Lymphoma--Can It Be Administered More Safely if Necessary? JAMA Oncol. 2016 Feb; 2(2):169-70. Straus DJ, Cahlon O. PMID: 26606467.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    33. Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma. J Nucl Med. 2016 May; 57(5):728-34. Schöder H, Zelenetz AD, Hamlin P, Gavane S, Horwitz S, Matasar M, Moskowitz A, Noy A, Palomba L, Portlock C, Straus D, Grewal R, Migliacci JC, Larson SM, Moskowitz CH. PMID: 26719374.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    34. Arteriovenous malformation embocure score: AVMES. J Neurointerv Surg. 2016 Jul; 8(7):685-91. Lopes DK, Moftakhar R, Straus D, Munich SA, Chaus F, Kaszuba MC. PMID: 26078359.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood. J Natl Cancer Inst. 2015 Apr; 107(4). Matasar MJ, Ford JS, Riedel ER, Salz T, Oeffinger KC, Straus DJ. PMID: 25717170.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. Lancet Oncol. 2015 Mar; 16(3):284-92. Moskowitz AJ, Schöder H, Yahalom J, McCall SJ, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz S, Kobos R, Kumar A, Matasar M, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Shukla N, Steinherz P, Straus D, Trippett T, Younes A, Zelenetz A, Moskowitz CH. PMID: 25683846.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    37. Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantation. Br J Haematol. 2015 Mar; 168(5):663-70. Straus DJ, Hamlin PA, Matasar MJ, Lia Palomba M, Drullinsky PR, Zelenetz AD, Gerecitano JF, Noy A, Hamilton AM, Elstrom R, Wegner B, Wortman K, Cella D. PMID: 25316653.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    38. Surgical management of low-grade gliomas. Semin Oncol. 2014 Aug; 41(4):458-467. Gerard CS, Straus D, Byrne RW. PMID: 25173139.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Radiotherapy should be omitted in most patients. Clin Adv Hematol Oncol. 2014 Apr; 12(4):247-9. Straus DJ. PMID: 25134171.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    40. Trauma deserts: distance from a trauma center, transport times, and mortality from gunshot wounds in Chicago. Am J Public Health. 2013 Jun; 103(6):1103-9. Crandall M, Sharp D, Unger E, Straus D, Brasel K, Hsia R, Esposito T. PMID: 23597339.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    41. Acupuncture for the treatment of post-chemotherapy chronic fatigue: a randomized, blinded, sham-controlled trial. Support Care Cancer. 2013 Jun; 21(6):1735-41. Deng G, Chan Y, Sjoberg D, Vickers A, Yeung KS, Kris M, Straus D, Cassileth B. PMID: 23334562.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    42. Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. PLoS Genet. 2013; 9(1):e1003220. Vijai J, Kirchhoff T, Schrader KA, Brown J, Dutra-Clarke AV, Manschreck C, Hansen N, Rau-Murthy R, Sarrel K, Przybylo J, Shah S, Cheguri S, Stadler Z, Zhang L, Paltiel O, Ben-Yehuda D, Viale A, Portlock C, Straus D, Lipkin SM, Lacher M, Robson M, Klein RJ, Zelenetz A, Offit K. PMID: 23349640.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    43. Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma. J Clin Oncol. 2013 Feb 01; 31(4):456-60. Moskowitz AJ, Hamlin PA, Perales MA, Gerecitano J, Horwitz SM, Matasar MJ, Noy A, Palomba ML, Portlock CS, Straus DJ, Graustein T, Zelenetz AD, Moskowitz CH. PMID: 23248254.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCTClinical Trials
    44. Long-term follow-up and survival of cutaneous T-cell lymphoma patients treated with extracorporeal photopheresis. Photodermatol Photoimmunol Photomed. 2012 Oct; 28(5):250-7. Knobler R, Duvic M, Querfeld C, Straus D, Horwitz S, Zain J, Foss F, Kuzel T, Campbell K, Geskin L. PMID: 22971190.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    45. Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone? Leuk Lymphoma. 2012 Nov; 53(11):2143-50. Kostakoglu L, Schöder H, Johnson JL, Hall NC, Schwartz LH, Straus DJ, LaCasce AS, Jung SH, Bartlett NL, Canellos GP, Cheson BD. PMID: 22421007.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    46. Clinical guidelines, the politics of value, and the practice of medicine: physicians at the crossroads. J Oncol Pract. 2012 Jul; 8(4):233-5. Cooper RA, Straus DJ. PMID: 23180988.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. A novel scoring system for assessing Chiari malformation type I treatment outcomes. Neurosurgery. 2012 Mar; 70(3):656-64; discussion 664-5. Aliaga L, Hekman KE, Yassari R, Straus D, Luther G, Chen J, Sampat A, Frim D. PMID: 21849925.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    48. Incidence of spontaneous remission in patients with CD25-positive mycosis fungoides/Sézary syndrome receiving placebo. J Am Acad Dermatol. 2012 Nov; 67(5):867-75. Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Straus DJ. PMID: 22285675.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    49. Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood. 2012 Feb 16; 119(7):1665-70. Moskowitz CH, Matasar MJ, Zelenetz AD, Nimer SD, Gerecitano J, Hamlin P, Horwitz S, Moskowitz AJ, Noy A, Palomba L, Perales MA, Portlock C, Straus D, Maragulia JC, Schoder H, Yahalom J. PMID: 22184409.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCTClinical Trials
    50. Chemotherapy alone for early-stage Hodgkin's lymphoma. N Engl J Med. 2012 Feb 02; 366(5):470-1. Straus DJ. PMID: 22149920.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    51. Recent results of treatment of early stage Hodgkin lymphoma: risk-adapted approaches. Leuk Lymphoma. 2011 May; 52(5):738-9. Straus DJ. PMID: 21504296.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    52. Long-term survivorship at a price: late-term, therapy-associated toxicities in the adult hodgkin lymphoma patient. Ther Adv Hematol. 2011 Apr; 2(2):111-9. Straus DJ. PMID: 23556081.
      View in: PubMed   Mentions:
    53. Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET. Blood. 2011 May 19; 117(20):5314-20. Straus DJ, Johnson JL, LaCasce AS, Bartlett NL, Kostakoglu L, Hsi ED, Schöder H, Hall NC, Jung SH, Canellos GP, Schwartz LH, Takvorian RW, Juweid ME, Cheson BD. PMID: 21355087.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    54. Phase I trial of weekly and twice-weekly bortezomib with rituximab, cyclophosphamide, and prednisone in relapsed or refractory non-Hodgkin lymphoma. Clin Cancer Res. 2011 Apr 15; 17(8):2493-501. Gerecitano J, Portlock C, Hamlin P, Moskowitz CH, Noy A, Straus D, Schulman P, Dumitrescu O, Sarasohn D, Pappanicholaou J, Iasonos A, Zhang Z, Mo Q, Horanlli E, Rojas CN, Zelenetz AD, O'Connor OA. PMID: 21346146.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    55. Necrobiotic xanthogranuloma associated with immunoglobulin m paraproteinemia in a patient with Waldenström macroglobulinemia. J Clin Oncol. 2011 Apr 10; 29(11):e305-7. Balagula Y, Straus DJ, Pulitzer MP, Lacouture ME. PMID: 21245419.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    56. Management options, survivorship, and emerging treatment strategies for follicular and Hodgkin lymphomas. Leuk Lymphoma. 2010 Aug; 51 Suppl 1:41-9. Czuczman M, Straus D, Gribben J, Bredenfeld H, Friedberg J, Bollard C. PMID: 20658953.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    57. Primary thyroid lymphoma, a rare disease with a good treatment outcome. J Surg Oncol. 2010 Jun 01; 101(7):543-4. Straus DJ. PMID: 20461758.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    58. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma. J Clin Oncol. 2010 Apr 10; 28(11):1896-903. Moskowitz CH, Schöder H, Teruya-Feldstein J, Sima C, Iasonos A, Portlock CS, Straus D, Noy A, Palomba ML, O'Connor OA, Horwitz S, Weaver SA, Meikle JL, Filippa DA, Caravelli JF, Hamlin PA, Zelenetz AD. PMID: 20212248.
      View in: PubMed   Mentions: 77     Fields:    Translation:Humans
    59. Phase III placebo-controlled trial of denileukin diftitox for patients with cutaneous T-cell lymphoma. J Clin Oncol. 2010 Apr 10; 28(11):1870-7. Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Sun Y, Straus D, Acosta M, Negro-Vilar A. PMID: 20212249.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    60. High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging. Br J Haematol. 2010 Mar; 148(6):890-7. Moskowitz CH, Yahalom J, Zelenetz AD, Zhang Z, Filippa D, Teruya-Feldstein J, Kewalramani T, Moskowitz AJ, Rice RD, Maragulia J, Vanak J, Trippett T, Hamlin P, Horowitz S, Noy A, O'Connor OA, Portlock C, Straus D, Nimer SD. PMID: 20085577.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    61. Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes. Clin Cancer Res. 2010 Jan 15; 16(2):719-26. O'Connor OA, Portlock C, Moskowitz C, Hamlin P, Straus D, Gerecitano J, Gonen M, Dumitrescu O, Sarasohn D, Butos J, Neylon E, Mac-Gregor Cortelli B, Blumel S, Evens AM, Zelenetz AD, Wright J, Cooper B, Winter J, Vose J. PMID: 20068103.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    62. The case for chemotherapy only for localized Hodgkin lymphoma. Oncologist. 2009 Dec; 14(12):1225-31. Straus DJ. PMID: 20007643.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    63. Phase 2 study of weekly bortezomib in mantle cell and follicular lymphoma. Br J Haematol. 2009 Sep; 146(6):652-5. Gerecitano J, Portlock C, Moskowitz C, Hamlin P, Straus D, Zelenetz AD, Zhang Z, Dumitrescu O, Sarasohn D, Lin D, Pappanicholaou J, Cortelli BM, Neylon E, Hamelers R, Wright J, O'Connor OA. PMID: 19624539.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCTClinical Trials
    64. Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial. Br J Haematol. 2009 Apr; 145(1):34-9. O'Connor OA, Moskowitz C, Portlock C, Hamlin P, Straus D, Dumitrescu O, Sarasohn D, Gonen M, Butos J, Neylon E, Hamelers R, Mac-Gregor Cortelli B, Blumel S, Zelenetz AD, Gordon L, Wright JJ, Vose J, Cooper B, Winter J. PMID: 19220284.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCTClinical Trials
    65. A multicentre phase II clinical experience with the novel aza-epothilone Ixabepilone (BMS247550) in patients with relapsed or refractory indolent non-Hodgkin lymphoma and mantle cell lymphoma. Br J Haematol. 2008 Oct; 143(2):201-9. O'Connor OA, Portlock C, Moskowitz C, Straus D, Hamlin P, Stubblefield M, Dumetrescu O, Colevas AD, Grant B, Zelenetz A. PMID: 18691173.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    66. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant. 2008 Jan; 14(1):59-66. Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ, Aboulafia DM, Scadden DT. PMID: 18158962.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    67. Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma. Br J Haematol. 2007 Nov; 139(3):425-8. O'Connor OA, Hamlin PA, Portlock C, Moskowitz CH, Noy A, Straus DJ, Macgregor-Cortelli B, Neylon E, Sarasohn D, Dumetrescu O, Mould DR, Fleischer M, Zelenetz AD, Sirotnak F, Horwitz S. PMID: 17910632.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    68. How I treat mantle cell lymphoma. J Oncol Pract. 2007 Sep; 3(5):281-2. Straus DJ. PMID: 20859426.
      View in: PubMed   Mentions: 1     Fields:    
    69. Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma. Cancer. 2007 May 01; 109(9):1799-803. Straus DJ, Duvic M, Kuzel T, Horwitz S, Demierre MF, Myskowski P, Steckel S. PMID: 17366595.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    70. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. Cancer. 2006 Oct 15; 107(8):1909-17. Straus DJ, Testa MA, Sarokhan BJ, Czuczman MS, Tulpule A, Turner RR, Riggs SA. PMID: 16977654.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    71. Treatment of early-stage nonbulky Hodgkin lymphoma. Curr Opin Oncol. 2006 Sep; 18(5):432-6. Straus DJ. PMID: 16894289.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. The role of PET in lymphoma. J Nucl Med. 2006 Aug; 47(8):1326-34. Jhanwar YS, Straus DJ. PMID: 16883013.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    73. Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation? Leuk Lymphoma. 2006 Jul; 47(7):1260-4. Portlock CS, O'Connor OA, Straus DJ, Rosenzweig L, Dumitrescu O, Lin O, Maslak P. PMID: 16923555.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    74. Management of anemia in patients with hematologic malignancies. Oncology (Williston Park). 2006 Jul; 20(8 Suppl 6):8-11. Straus DJ. PMID: 16925104.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    75. Treatment of Burkitt lymphoma in adults. Expert Rev Anticancer Ther. 2006 Mar; 6(3):373-81. Gerecitano J, Straus DJ. PMID: 16503854.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Management of early stage Hodgkin's lymphoma. Cancer Treat Res. 2006; 131:317-32. Straus DJ. PMID: 16704174.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    77. Comparative studies on erythropoietic agents. J Natl Compr Canc Netw. 2005 Nov; 3 Suppl 1:S46-9. Straus D. PMID: 16280113.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    78. Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999. Br J Haematol. 2005 Sep; 130(5):691-9. Hamlin PA, Portlock CS, Straus DJ, Noy A, Singer A, Horwitz SM, Oconnor OA, Yahalom J, Zelenetz AD, Moskowitz CH. PMID: 16115124.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    79. Treatment of anemia with erythropoietic agents in patients with hematologic malignancies. Support Cancer Ther. 2005 Jul 01; 2(4):215-24. Straus DJ. PMID: 18628176.
      View in: PubMed   Mentions:
    80. R-CHOP-14 in patients with diffuse large B-cell lymphoma: feasibility and preliminary efficacy. Leuk Lymphoma. 2005 Apr; 46(4):541-7. Halaas JL, Moskowitz CH, Horwitz S, Portlock C, Noy A, Straus D, O'Connor OA, Yahalom J, Zelenetz AD. PMID: 16019482.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    81. HIV-associated lymphoma: promising new results, but with toxicity. Blood. 2005 Mar 01; 105(5):1842. Straus DJ. PMID: 15747398.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    82. Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma. J Clin Oncol. 2005 Feb 01; 23(4):676-84. O'Connor OA, Wright J, Moskowitz C, Muzzy J, MacGregor-Cortelli B, Stubblefield M, Straus D, Portlock C, Hamlin P, Choi E, Dumetrescu O, Esseltine D, Trehu E, Adams J, Schenkein D, Zelenetz AD. PMID: 15613699.
      View in: PubMed   Mentions: 128     Fields:    Translation:HumansCTClinical Trials
    83. Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II. J Natl Compr Canc Netw. 2004 Nov; 2 Suppl 4:S21-2. O'Connor O, Wright J, Moskowitz CH, Muzzy J, MacGregor-Cortelli B, Hamlin P, Straus D, Trehu E, Schenkein DP, Zelenetz AD. PMID: 19791425.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    84. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease. Blood. 2004 Dec 01; 104(12):3483-9. Straus DJ, Portlock CS, Qin J, Myers J, Zelenetz AD, Moskowitz C, Noy A, Goy A, Yahalom J. PMID: 15315964.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    85. Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease. Br J Haematol. 2004 Jun; 125(6):701-8. Portlock CS, Donnelly GB, Qin J, Straus D, Yahalom J, Zelenetz A, Noy A, O'Connor O, Horwitz S, Moskowitz C, Filippa DA. PMID: 15180859.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    86. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol. 2004 May 01; 22(9):1731-5. Vickers AJ, Straus DJ, Fearon B, Cassileth BR. PMID: 15117996.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    87. Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2004 May 15; 103(10):3684-8. Kewalramani T, Zelenetz AD, Nimer SD, Portlock C, Straus D, Noy A, O'Connor O, Filippa DA, Teruya-Feldstein J, Gencarelli A, Qin J, Waxman A, Yahalom J, Moskowitz CH. PMID: 14739217.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCTClinical Trials
    88. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer. 2003 Sep 15; 98(6):1196-205. Wang ES, Straus DJ, Teruya-Feldstein J, Qin J, Portlock C, Moskowitz C, Goy A, Hedrick E, Zelenetz AD, Noy A. PMID: 12973843.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    89. Epoetin alfa therapy for patients with hematologic malignancies and mild anemia. Clin Lymphoma. 2003 Aug; 4 Suppl 1:S13-7. Straus DJ. PMID: 14556671.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    90. Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2003 Sep 15; 102(6):1989-96. Hamlin PA, Zelenetz AD, Kewalramani T, Qin J, Satagopan JM, Verbel D, Noy A, Portlock CS, Straus DJ, Yahalom J, Nimer SD, Moskowitz CH. PMID: 12676776.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    91. Gallium nitrate in the treatment of lymphoma. Semin Oncol. 2003 Apr; 30(2 Suppl 5):25-33. Straus DJ. PMID: 12776257.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    92. Epoetin alfa as a supportive measure in hematologic malignancies. Semin Hematol. 2002 Oct; 39(4 Suppl 3):25-31. Straus DJ. PMID: 12447849.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    93. Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation. Cancer J. 2002 Sep-Oct; 8(5):371-6. Pan D, Moskowitz CH, Zelenetz AD, Straus D, Kewalaramani T, Noy A, Qin J, Teruya-Feldstein J, Portlock CS. PMID: 12416894.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Impact of early response to sequential high-dose chemotherapy on outcome of patients with advanced myeloma and poor prognostic features. Leuk Lymphoma. 2002 Mar; 43(3):607-12. Niesvizky R, Siegel D, Glassman J, Straus D, Fine J, Lyons L, Michaeli J. PMID: 12002766.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    95. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma. Recent Results Cancer Res. 2002; 159:143-8. Straus DJ. PMID: 11785838.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials